RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett
DOI: 10.1055/a-2716-2853
DOI: 10.1055/a-2716-2853
Letter
Nickel-Catalyzed Enantioconvergent Cycloadditions of Aziridines and Imines
Autoren
Gefördert durch: Masuyakinen Basic Research Foundation
Gefördert durch: Grants-in-Aid for Scientific Research from MEXT (Japan) 20H02737,23K20277
Gefördert durch: Kumagai Science and Technology Foundation
Gefördert durch: Toshiaki Ogasawara Memorial Foundation
Gefördert durch: Murata Science Foundation
Gefördert durch: Iketani Science and Technology Foundation
Funding Information This work was supported by Grants-in-Aid for Scientific Research (Nos. 20H02737, and 23K20277) from MEXT (Japan). We acknowledge the Masuyakinen Basic Research Foundation, Murata Science Foundation, Toshiaki Ogasawara Memorial Foundation, Kumagai Science and Technology Foundation, and Iketani Science and Technology Foundation.

Abstract
We report asymmetric nickel-catalyzed cycloadditions of aziridines and imines enabled by a newly designed tyrosine-derived FOXAP ligand, delivering up to 97% ee and >20:1 dr. The reaction constructs imidazolidines bearing two nonadjacent stereocenters from racemic vinylaziridines and achiral imines in an enantioconvergent manner.
Publikationsverlauf
Eingereicht: 13. September 2025
Angenommen nach Revision: 30. September 2025
Artikel online veröffentlicht:
31. Oktober 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Trost BM, Osipov M, Dong G. J Am Chem Soc 2010; 132: 15800
- 2 Steiman TJ, Liu J, Mengiste A, Doyle AG. J Am Chem Soc 2020; 142: 7598
- 3 Allen BDW, Lakeland CP, Harrity JPA. Chem Eur J 2017; 23: 13830
- 4a Chai Z, Zhu Y-M, Yang P-J. et al. J Am Chem Soc 2015; 137: 10088
- 4b Rivinoja DJ, Gee YS, Gardiner MG, Ryan JH, Hyland CJT. ACS Catal 2017; 7: 1053
- 5 Hirner JJ, Roth KE, Shi Y, Blum SA. Organometallics 2012; 31: 6843
- 6 Feng J-J, Lin T-Y, Zhu C-Z, Wang H, Wu H-H, Zhang J. J Am Chem Soc 2016; 138: 2178
- 7 Feng J-J, Lin T-Y, Wu H-H, Zhang J. J Am Chem Soc 2015; 137: 3787
- 8 Xu C-F, Zheng B-H, Suo J-J, Ding C-H, Hou X-L. Angew Chem, Int Ed 2015; 54: 1604
- 9 Lowe MA, Ostovar M, Ferrini S. et al. Angew Chem, Int Ed 2011; 50: 6370
- 10 Arena G, Chen CC, Leonori D, Aggarwal VK. Org Lett 2013; 15: 4250
- 11 Næsborg L, Tur F, Meazza M, Blom J, Halskov KS, Jørgensen KA. Chem Eur J 2017; 23: 268
- 12 Lin T-Y, Zhu C-Z, Zhang P. et al. Angew Chem, Int Ed 2016; 55: 10844
- 13a Yang P-J, Qi L, Liu Z, Yang G, Chai Z. J Am Chem Soc 2018; 140: 17211
- 13b Teranishi S, Maeda K, Kurahashi T, Matsubara S. Org Lett 2019; 21: 2593
- 14 Fontana F, Chen CC, Aggarwal VK. Org Lett 2011; 13: 3454
- 15 Chai Z. Synthesis 2020; 52: 1738
- 16 Lin T-Y, Wu H-H, Feng J-J, Zhang J. Org Lett 2018; 20: 3587
- 17 Trost BM, Fandrick DR. J Am Chem Soc 2003; 125: 11836
- 18 Spielmann K, Tosi E, Lebrun A. et al. Tetrahedron 2018; 74: 6497
- 19 Qiao J, Wang S, Liu X, Feng X. Chem Eur J 2023; 29: e202203757
- 20a Nishibayashi Y, Uemura S. Synlett 1995; 79
- 20b Connon R, Roche B, Rokade BV, Guiry PJ. Chem Rev 2021; 121: 6373
- 21 GazićSmilovic I, Casas-Arcé E, Roseblade SJ. et al. Angew Chem, Int Ed 2012; 51: 1014
- 22 Clavier H, Nolan SP. Chem Commun 2010; 46: 841
- 23 Hillier AC, Sommer WJ, Yong BS, Petersen JL, Cavallo L, Nolan SP. Organometallics 2003; 22: 4322
- 24 Falivene L, Cao Z, Petta A. et al. Nat Chem 2019; 11: 872
- 25a Taft Jr RW. J Am Chem Soc 1952; 72: 2729
- 25b Charton M. J Am Chem Soc 1975; 97: 1552
- 25c Verloop A. Drug Design. New York: Academic Press; 1976
- 25d Tolman CA. Chem Rev 1977; 77: 313
- 25e van Leeuwen PWNM, Kamer PCJ, Reek JNH, Dierkes P. Chem Rev 2000; 100: 2741
- 25f Solid G, Guzei IA, Wendt M. Dalton Trans 2006; 3991
- 25g Fey N, Harvey JN. et al. Organometallics 2008; 27: 1372
- 25h Poater A, Ragone F, Mariz R, Dorta R, Cavallo L. Chem Eur J 2010; 16: 14348
- 25i Dunne BJ, Morris RB, Orpen AG. J Chem Soc, Dalton Trans 1991; 653
- 25j Santiago CB, Guo J-Y, Sigman MS. Chem Sci 2018; 9: 2398
- 25k Escayola S, Bahri-Laleh N, Poater A. Chem Soc Rev 2024; 53: 853
- 26a Vineyard BD, Knowles WS, Sabacky MJ, Bachman GL, Weinkauff DJ. J Am Chem Soc 1977; 99: 5946
- 26b Knowles WS. Acc Chem Res 1983; 16: 106
- 27 It should be noted that the cross-sectional value originated to ligand at radial distance r is equal to the square of radius r multiplied by 4π and %A occ. Hence, the fact that %A occ is almost constant at ca. 20% for orange line, NW+z direction, around ~9 Å means that the tyrosine-derived FOXAP ligand has the unique three-dimensionally spreading substituent
FOXAP ligand:
For recent review of oxazoline containing chiral ligands:
Taft parameter:
Charton parameter:
Sterimol values:
Tolman cone angle:
Bond lengths:
Bite angles:
Topographic steric maps:
Steric hindrance index: